CNP
49
-6
AME
72
6
STX
69
2
LNC
75
2
IP
28
-3
PVH
32
2
ALL
56
2
MUR
36
3
AON
62
-5
EW
58
5
STZ
42
-2
CRM
70
18
FFIV
47
-3
DRI
66
2
GILD
56
6
FE
48
-4
EOG
33
-3
CF
48
4
ECL
57
3
AIG
77
2
CNP
49
-6
AME
72
6
STX
69
2
LNC
75
2
IP
28
-3
PVH
32
2
ALL
56
2
MUR
36
3
AON
62
-5
EW
58
5
STZ
42
-2
CRM
70
18
FFIV
47
-3
DRI
66
2
GILD
56
6
FE
48
-4
EOG
33
-3
CF
48
4
ECL
57
3
AIG
77
2
Financhill
Back

RBC Target 2027 Canadian Corporate Bond Index ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
39

RQP.TO
RBC Target 2027 Canadian Corporate Bond Index ETF

Last Price:
$18.39
Seasonality Move:
0.41%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
39
RBC Target 2027 Canadian Corporate Bond Index ETF (RQP.TO) is a Sell

Is RBC Target 2027 Canadian Corporate Bond Index ETF a Buy, Sell or Hold?

  • The current RBC Target 2027 Canadian Corporate Bond Index ETF [RQP.TO] share price is $18.39. The Score for RQP.TO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • RQP.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RQP.TO Stock Price Chart

What is RBC Target 2027 Canadian Corporate Bond Index ETF's stock price today?

  • The RBC Target 2027 Canadian Corporate Bond Index ETF share price today is $18.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RQP.TO is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

RQP.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.46 Buy
Relative Strength Index (14 RSI): 43.77 Sell
Chaikin Money Flow: -26883 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.38 - 18.42) Sell
Bollinger Bands (100): (18.39 - 18.45) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

RQP.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.4 Sell
20-day SMA: 18.4 Sell
50-day SMA: 18.43 Sell
200-day SMA: 18.4 Sell
8-day EMA: 9.74 Buy
20-day EMA: 4.77 Buy
50-day EMA: 2.08 Buy
200-day EMA: 0.54 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

RBC Target 2027 Canadian Corporate Bond Index ETF Earnings Growth & RQP.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

RBC Target 2027 Canadian Corporate Bond Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):